Bioventus Inc. Files Q1 2025 10-Q
Ticker: BVS · Form: 10-Q · Filed: May 6, 2025 · CIK: 1665988
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Bioventus Q1 2025 10-Q filed. Financials look steady.
AI Summary
Bioventus Inc. filed its 10-Q for the period ending March 29, 2025. The filing details financial performance and operational updates for the first quarter of fiscal year 2025. Key financial data and business segment information are presented, reflecting the company's ongoing activities in the surgical and medical instruments sector.
Why It Matters
This filing provides investors with an update on Bioventus Inc.'s financial health and operational performance for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the medical device sector can be subject to regulatory and market risks not detailed in this summary.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of fiscal year 2025)
- 1231 — Fiscal Year End (Indicates the company's annual financial cycle)
Key Players & Entities
- Bioventus Inc. (company) — Filer of the 10-Q
- 20250329 (date) — End of the reporting period
- 20250506 (date) — Filing date
- DURHAM, NC (location) — Company headquarters
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 29, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 6, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the business address of Bioventus Inc.?
The business address is 4721 Emperor Boulevard, Suite 100, Durham, NC 27703.
What is the Standard Industrial Classification (SIC) code for Bioventus Inc.?
The SIC code is 3841, for Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Bioventus Inc. (BVS).